Latest News in the pharma Industry

Market News

Sangamo and Pfizer collaborate to develop zinc finger protein gene therapy for ALS

Sangamo and Pfizer collaborate to develop zinc finger protein gene therapy for ALS

7 Jan 2018

"The precision and flexibility of zinc finger proteins enables targeting of virtually any genetic mutation."

Read more 
SSB to equip Abzena's US-based development and manufacturing sites

SSB to equip Abzena's US-based development and manufacturing sites

4 Jan 2018

SSB will provide both facilities with end-to-end process solutions in single-use format.

Read more 
Momenta and Mylan to development proposed biosimilar to Eylea

Momenta and Mylan to development proposed biosimilar to Eylea

4 Jan 2018

Targeting the initiation of a pivotal patient clinical trial in the first half of 2018.

Read more 
Junior Filters for space restricted applications

Junior Filters for space restricted applications

3 Jan 2018

Ideal for a wide variety of pharmaceutical applications.

Read more 
Scholar Rock announces $47 million Series C financing to advance innovative pipeline

Scholar Rock announces $47 million Series C financing to advance innovative pipeline

3 Jan 2018

SRK-015 to move into clinical development for Spinal Muscular Atrophy (SMA) in first half of 2018; development in additional neuromuscular disorders to follow.

Read more 
Recipharm acquires remaining shares in Nitin Lifesciences

Recipharm acquires remaining shares in Nitin Lifesciences

2 Jan 2018

The transaction will allow Recipharm to combine and better exploit operational synergies with the company's other Indian business.

Read more 
Juniper Pharma Services’ co-founder awarded CBE in the Queen’s New Year’s Honours List

Juniper Pharma Services’ co-founder awarded CBE in the Queen’s New Year’s Honours List

2 Jan 2018

Martyn Davies recognised for his contribution to UK science and his ground-breaking achievements in pharmaceutical research and drug development.

Read more 
Novel Sorrento CAR-T technology a potential “game-changer

Novel Sorrento CAR-T technology a potential “game-changer

2 Jan 2018

Company envisions the development and IND filings of multiple “next-frontier” CAR-T programs in 2018 and beyond, which will position the company as a potential major player in the fast-growing CAR-T space of immunotherapies against cancers.

Read more 
ANVISA approves Biocon and Mylan's biosimilar Trastuzumab

ANVISA approves Biocon and Mylan's biosimilar Trastuzumab

29 Dec 2017

Libbs will commercialize the product in Brazil under the brand name Zedora.

Read more 
FDA approves first generic for Estrace Cream

FDA approves first generic for Estrace Cream

29 Dec 2017

Mylan now offers estradiol in four delivery methods.

Read more 
Shire files for FDA approval of a new plasma manufacturing facility

Shire files for FDA approval of a new plasma manufacturing facility

28 Dec 2017

The additional capacity from this site is a key element to support the growth in the company's Immunology franchise.

Read more 
Teva launches generic version of Reyataz in the US

Teva launches generic version of Reyataz in the US

28 Dec 2017

The exclusive launch of Teva's generic version of Reyataz marks the company's fifth generic product offering for the treatment of HIV-1 infection.

Read more